Global Oligonucleotide CDMO and CRDMO Services Market Growth (Status and Outlook) 2025-2031
The global Oligonucleotide CDMO and CRDMO Services market size is predicted to grow from US$ 1657 million in 2025 to US$ 2745 million in 2031; it is expected to grow at a CAGR of 8.8% from 2025 to 2031.
Oligonucleotide CDMO (Contract Development and Manufacturing Organization) and CRDMO (Contract Research, Development, and Manufacturing Organization) services provide end-to-end solutions for biopharmaceutical companies and research institutions, covering the entire process from R&D to commercial production. These services include process development, synthesis, purification, analytical method development, quality control, GMP manufacturing, and regulatory support. While CDMO primarily focuses on production and process optimization, CRDMO extends to early-stage research and preclinical development. With the rapid advancement of gene and RNA-based therapies, the demand for high-quality, regulatory-compliant oligonucleotide synthesis and manufacturing continues to grow, driving technological innovation and industrial capabilities in CDMO and CRDMO companies.
United States market for Oligonucleotide CDMO and CRDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oligonucleotide CDMO and CRDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oligonucleotide CDMO and CRDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oligonucleotide CDMO and CRDMO Services players cover ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Oligonucleotide CDMO and CRDMO Services Industry Forecast” looks at past sales and reviews total world Oligonucleotide CDMO and CRDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide CDMO and CRDMO Services sales for 2025 through 2031. With Oligonucleotide CDMO and CRDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide CDMO and CRDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide CDMO and CRDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide CDMO and CRDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide CDMO and CRDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide CDMO and CRDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide CDMO and CRDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide CDMO and CRDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Oligonucleotide CDMO (Contract Development and Manufacturing Organization) and CRDMO (Contract Research, Development, and Manufacturing Organization) services provide end-to-end solutions for biopharmaceutical companies and research institutions, covering the entire process from R&D to commercial production. These services include process development, synthesis, purification, analytical method development, quality control, GMP manufacturing, and regulatory support. While CDMO primarily focuses on production and process optimization, CRDMO extends to early-stage research and preclinical development. With the rapid advancement of gene and RNA-based therapies, the demand for high-quality, regulatory-compliant oligonucleotide synthesis and manufacturing continues to grow, driving technological innovation and industrial capabilities in CDMO and CRDMO companies.
United States market for Oligonucleotide CDMO and CRDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Oligonucleotide CDMO and CRDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Oligonucleotide CDMO and CRDMO Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Oligonucleotide CDMO and CRDMO Services players cover ST Pharm, EUROAPI, Danaher(IDT), Merck, Eurofins Scientific, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Oligonucleotide CDMO and CRDMO Services Industry Forecast” looks at past sales and reviews total world Oligonucleotide CDMO and CRDMO Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide CDMO and CRDMO Services sales for 2025 through 2031. With Oligonucleotide CDMO and CRDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide CDMO and CRDMO Services industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide CDMO and CRDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oligonucleotide CDMO and CRDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oligonucleotide CDMO and CRDMO Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide CDMO and CRDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide CDMO and CRDMO Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide CDMO and CRDMO Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Non-GMP Oligonucleotides
- GMP Oligonucleotides
- Pharmaceuticals
- Scientific Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ST Pharm
- EUROAPI
- Danaher(IDT)
- Merck
- Eurofins Scientific
- Thermo Fisher Scientific
- Agilent Technologies
- Nippon Shokubai
- Eurogentec
- Ajinomoto Bio-Pharma
- PeptiStar
- Bachem
- CordenPharma
- Guangzhou RiboBio
- Hongene Biotech
- WuXi AppTec
- Veliter
- Ribobay Pharma
- ChemExpress
- Asymchem
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide CDMO and CRDMO Services Market Size (2020-2031)
2.1.2 Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oligonucleotide CDMO and CRDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Oligonucleotide CDMO and CRDMO Services Segment by Type
2.2.1 Non-GMP Oligonucleotides
2.2.2 GMP Oligonucleotides
2.3 Oligonucleotide CDMO and CRDMO Services Market Size by Type
2.3.1 Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
2.4 Oligonucleotide CDMO and CRDMO Services Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Oligonucleotide CDMO and CRDMO Services Market Size by Application
2.5.1 Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
3 OLIGONUCLEOTIDE CDMO AND CRDMO SERVICES MARKET SIZE BY PLAYER
3.1 Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Player
3.1.1 Global Oligonucleotide CDMO and CRDMO Services Revenue by Player (2020-2025)
3.1.2 Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Oligonucleotide CDMO and CRDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE CDMO AND CRDMO SERVICES BY REGION
4.1 Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025)
4.2 Global Oligonucleotide CDMO and CRDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
4.4 APAC Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
4.5 Europe Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025)
5.2 Americas Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
5.3 Americas Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025)
6.2 APAC Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
6.3 APAC Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025)
7.2 Europe Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
7.3 Europe Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide CDMO and CRDMO Services by Region (2020-2025)
8.2 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OLIGONUCLEOTIDE CDMO AND CRDMO SERVICES MARKET FORECAST
10.1 Global Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.1.1 Global Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Oligonucleotide CDMO and CRDMO Services Forecast
10.1.3 APAC Oligonucleotide CDMO and CRDMO Services Forecast
10.1.4 Europe Oligonucleotide CDMO and CRDMO Services Forecast
10.1.5 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Forecast
10.2 Americas Oligonucleotide CDMO and CRDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Oligonucleotide CDMO and CRDMO Services Forecast
10.2.2 Canada Market Oligonucleotide CDMO and CRDMO Services Forecast
10.2.3 Mexico Market Oligonucleotide CDMO and CRDMO Services Forecast
10.2.4 Brazil Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3 APAC Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.3.1 China Oligonucleotide CDMO and CRDMO Services Market Forecast
10.3.2 Japan Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.3 Korea Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.4 Southeast Asia Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.5 India Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.6 Australia Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4 Europe Oligonucleotide CDMO and CRDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.2 France Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.3 UK Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.4 Italy Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.5 Russia Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5.2 South Africa Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5.3 Israel Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5.4 Turkey Market Oligonucleotide CDMO and CRDMO Services Forecast
10.6 Global Oligonucleotide CDMO and CRDMO Services Forecast by Type (2026-2031)
10.7 Global Oligonucleotide CDMO and CRDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oligonucleotide CDMO and CRDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 ST Pharm
11.1.1 ST Pharm Company Information
11.1.2 ST Pharm Oligonucleotide CDMO and CRDMO Services Product Offered
11.1.3 ST Pharm Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 ST Pharm Main Business Overview
11.1.5 ST Pharm Latest Developments
11.2 EUROAPI
11.2.1 EUROAPI Company Information
11.2.2 EUROAPI Oligonucleotide CDMO and CRDMO Services Product Offered
11.2.3 EUROAPI Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 EUROAPI Main Business Overview
11.2.5 EUROAPI Latest Developments
11.3 Danaher(IDT)
11.3.1 Danaher(IDT) Company Information
11.3.2 Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Product Offered
11.3.3 Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Danaher(IDT) Main Business Overview
11.3.5 Danaher(IDT) Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Oligonucleotide CDMO and CRDMO Services Product Offered
11.4.3 Merck Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Information
11.5.2 Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
11.5.3 Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Eurofins Scientific Main Business Overview
11.5.5 Eurofins Scientific Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
11.6.3 Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Information
11.7.2 Agilent Technologies Oligonucleotide CDMO and CRDMO Services Product Offered
11.7.3 Agilent Technologies Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Agilent Technologies Main Business Overview
11.7.5 Agilent Technologies Latest Developments
11.8 Nippon Shokubai
11.8.1 Nippon Shokubai Company Information
11.8.2 Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Product Offered
11.8.3 Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Nippon Shokubai Main Business Overview
11.8.5 Nippon Shokubai Latest Developments
11.9 Eurogentec
11.9.1 Eurogentec Company Information
11.9.2 Eurogentec Oligonucleotide CDMO and CRDMO Services Product Offered
11.9.3 Eurogentec Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eurogentec Main Business Overview
11.9.5 Eurogentec Latest Developments
11.10 Ajinomoto Bio-Pharma
11.10.1 Ajinomoto Bio-Pharma Company Information
11.10.2 Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
11.10.3 Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ajinomoto Bio-Pharma Main Business Overview
11.10.5 Ajinomoto Bio-Pharma Latest Developments
11.11 PeptiStar
11.11.1 PeptiStar Company Information
11.11.2 PeptiStar Oligonucleotide CDMO and CRDMO Services Product Offered
11.11.3 PeptiStar Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 PeptiStar Main Business Overview
11.11.5 PeptiStar Latest Developments
11.12 Bachem
11.12.1 Bachem Company Information
11.12.2 Bachem Oligonucleotide CDMO and CRDMO Services Product Offered
11.12.3 Bachem Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bachem Main Business Overview
11.12.5 Bachem Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Oligonucleotide CDMO and CRDMO Services Product Offered
11.13.3 CordenPharma Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
11.14 Guangzhou RiboBio
11.14.1 Guangzhou RiboBio Company Information
11.14.2 Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Product Offered
11.14.3 Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Guangzhou RiboBio Main Business Overview
11.14.5 Guangzhou RiboBio Latest Developments
11.15 Hongene Biotech
11.15.1 Hongene Biotech Company Information
11.15.2 Hongene Biotech Oligonucleotide CDMO and CRDMO Services Product Offered
11.15.3 Hongene Biotech Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Hongene Biotech Main Business Overview
11.15.5 Hongene Biotech Latest Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Information
11.16.2 WuXi AppTec Oligonucleotide CDMO and CRDMO Services Product Offered
11.16.3 WuXi AppTec Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 WuXi AppTec Main Business Overview
11.16.5 WuXi AppTec Latest Developments
11.17 Veliter
11.17.1 Veliter Company Information
11.17.2 Veliter Oligonucleotide CDMO and CRDMO Services Product Offered
11.17.3 Veliter Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Veliter Main Business Overview
11.17.5 Veliter Latest Developments
11.18 Ribobay Pharma
11.18.1 Ribobay Pharma Company Information
11.18.2 Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
11.18.3 Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Ribobay Pharma Main Business Overview
11.18.5 Ribobay Pharma Latest Developments
11.19 ChemExpress
11.19.1 ChemExpress Company Information
11.19.2 ChemExpress Oligonucleotide CDMO and CRDMO Services Product Offered
11.19.3 ChemExpress Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 ChemExpress Main Business Overview
11.19.5 ChemExpress Latest Developments
11.20 Asymchem
11.20.1 Asymchem Company Information
11.20.2 Asymchem Oligonucleotide CDMO and CRDMO Services Product Offered
11.20.3 Asymchem Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Asymchem Main Business Overview
11.20.5 Asymchem Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide CDMO and CRDMO Services Market Size (2020-2031)
2.1.2 Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Oligonucleotide CDMO and CRDMO Services by Country/Region (2020, 2024 & 2031)
2.2 Oligonucleotide CDMO and CRDMO Services Segment by Type
2.2.1 Non-GMP Oligonucleotides
2.2.2 GMP Oligonucleotides
2.3 Oligonucleotide CDMO and CRDMO Services Market Size by Type
2.3.1 Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
2.4 Oligonucleotide CDMO and CRDMO Services Segment by Application
2.4.1 Pharmaceuticals
2.4.2 Scientific Research
2.5 Oligonucleotide CDMO and CRDMO Services Market Size by Application
2.5.1 Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
3 OLIGONUCLEOTIDE CDMO AND CRDMO SERVICES MARKET SIZE BY PLAYER
3.1 Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Player
3.1.1 Global Oligonucleotide CDMO and CRDMO Services Revenue by Player (2020-2025)
3.1.2 Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Player (2020-2025)
3.2 Global Oligonucleotide CDMO and CRDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OLIGONUCLEOTIDE CDMO AND CRDMO SERVICES BY REGION
4.1 Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025)
4.2 Global Oligonucleotide CDMO and CRDMO Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
4.4 APAC Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
4.5 Europe Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025)
5.2 Americas Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
5.3 Americas Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025)
6.2 APAC Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
6.3 APAC Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025)
7.2 Europe Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
7.3 Europe Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide CDMO and CRDMO Services by Region (2020-2025)
8.2 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL OLIGONUCLEOTIDE CDMO AND CRDMO SERVICES MARKET FORECAST
10.1 Global Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.1.1 Global Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.1.2 Americas Oligonucleotide CDMO and CRDMO Services Forecast
10.1.3 APAC Oligonucleotide CDMO and CRDMO Services Forecast
10.1.4 Europe Oligonucleotide CDMO and CRDMO Services Forecast
10.1.5 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Forecast
10.2 Americas Oligonucleotide CDMO and CRDMO Services Forecast by Country (2026-2031)
10.2.1 United States Market Oligonucleotide CDMO and CRDMO Services Forecast
10.2.2 Canada Market Oligonucleotide CDMO and CRDMO Services Forecast
10.2.3 Mexico Market Oligonucleotide CDMO and CRDMO Services Forecast
10.2.4 Brazil Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3 APAC Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.3.1 China Oligonucleotide CDMO and CRDMO Services Market Forecast
10.3.2 Japan Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.3 Korea Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.4 Southeast Asia Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.5 India Market Oligonucleotide CDMO and CRDMO Services Forecast
10.3.6 Australia Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4 Europe Oligonucleotide CDMO and CRDMO Services Forecast by Country (2026-2031)
10.4.1 Germany Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.2 France Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.3 UK Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.4 Italy Market Oligonucleotide CDMO and CRDMO Services Forecast
10.4.5 Russia Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5 Middle East & Africa Oligonucleotide CDMO and CRDMO Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5.2 South Africa Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5.3 Israel Market Oligonucleotide CDMO and CRDMO Services Forecast
10.5.4 Turkey Market Oligonucleotide CDMO and CRDMO Services Forecast
10.6 Global Oligonucleotide CDMO and CRDMO Services Forecast by Type (2026-2031)
10.7 Global Oligonucleotide CDMO and CRDMO Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Oligonucleotide CDMO and CRDMO Services Forecast
11 KEY PLAYERS ANALYSIS
11.1 ST Pharm
11.1.1 ST Pharm Company Information
11.1.2 ST Pharm Oligonucleotide CDMO and CRDMO Services Product Offered
11.1.3 ST Pharm Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 ST Pharm Main Business Overview
11.1.5 ST Pharm Latest Developments
11.2 EUROAPI
11.2.1 EUROAPI Company Information
11.2.2 EUROAPI Oligonucleotide CDMO and CRDMO Services Product Offered
11.2.3 EUROAPI Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 EUROAPI Main Business Overview
11.2.5 EUROAPI Latest Developments
11.3 Danaher(IDT)
11.3.1 Danaher(IDT) Company Information
11.3.2 Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Product Offered
11.3.3 Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Danaher(IDT) Main Business Overview
11.3.5 Danaher(IDT) Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Oligonucleotide CDMO and CRDMO Services Product Offered
11.4.3 Merck Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Information
11.5.2 Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
11.5.3 Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Eurofins Scientific Main Business Overview
11.5.5 Eurofins Scientific Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
11.6.3 Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Agilent Technologies
11.7.1 Agilent Technologies Company Information
11.7.2 Agilent Technologies Oligonucleotide CDMO and CRDMO Services Product Offered
11.7.3 Agilent Technologies Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Agilent Technologies Main Business Overview
11.7.5 Agilent Technologies Latest Developments
11.8 Nippon Shokubai
11.8.1 Nippon Shokubai Company Information
11.8.2 Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Product Offered
11.8.3 Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Nippon Shokubai Main Business Overview
11.8.5 Nippon Shokubai Latest Developments
11.9 Eurogentec
11.9.1 Eurogentec Company Information
11.9.2 Eurogentec Oligonucleotide CDMO and CRDMO Services Product Offered
11.9.3 Eurogentec Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Eurogentec Main Business Overview
11.9.5 Eurogentec Latest Developments
11.10 Ajinomoto Bio-Pharma
11.10.1 Ajinomoto Bio-Pharma Company Information
11.10.2 Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
11.10.3 Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Ajinomoto Bio-Pharma Main Business Overview
11.10.5 Ajinomoto Bio-Pharma Latest Developments
11.11 PeptiStar
11.11.1 PeptiStar Company Information
11.11.2 PeptiStar Oligonucleotide CDMO and CRDMO Services Product Offered
11.11.3 PeptiStar Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 PeptiStar Main Business Overview
11.11.5 PeptiStar Latest Developments
11.12 Bachem
11.12.1 Bachem Company Information
11.12.2 Bachem Oligonucleotide CDMO and CRDMO Services Product Offered
11.12.3 Bachem Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Bachem Main Business Overview
11.12.5 Bachem Latest Developments
11.13 CordenPharma
11.13.1 CordenPharma Company Information
11.13.2 CordenPharma Oligonucleotide CDMO and CRDMO Services Product Offered
11.13.3 CordenPharma Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 CordenPharma Main Business Overview
11.13.5 CordenPharma Latest Developments
11.14 Guangzhou RiboBio
11.14.1 Guangzhou RiboBio Company Information
11.14.2 Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Product Offered
11.14.3 Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Guangzhou RiboBio Main Business Overview
11.14.5 Guangzhou RiboBio Latest Developments
11.15 Hongene Biotech
11.15.1 Hongene Biotech Company Information
11.15.2 Hongene Biotech Oligonucleotide CDMO and CRDMO Services Product Offered
11.15.3 Hongene Biotech Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Hongene Biotech Main Business Overview
11.15.5 Hongene Biotech Latest Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Information
11.16.2 WuXi AppTec Oligonucleotide CDMO and CRDMO Services Product Offered
11.16.3 WuXi AppTec Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 WuXi AppTec Main Business Overview
11.16.5 WuXi AppTec Latest Developments
11.17 Veliter
11.17.1 Veliter Company Information
11.17.2 Veliter Oligonucleotide CDMO and CRDMO Services Product Offered
11.17.3 Veliter Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Veliter Main Business Overview
11.17.5 Veliter Latest Developments
11.18 Ribobay Pharma
11.18.1 Ribobay Pharma Company Information
11.18.2 Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
11.18.3 Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Ribobay Pharma Main Business Overview
11.18.5 Ribobay Pharma Latest Developments
11.19 ChemExpress
11.19.1 ChemExpress Company Information
11.19.2 ChemExpress Oligonucleotide CDMO and CRDMO Services Product Offered
11.19.3 ChemExpress Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 ChemExpress Main Business Overview
11.19.5 ChemExpress Latest Developments
11.20 Asymchem
11.20.1 Asymchem Company Information
11.20.2 Asymchem Oligonucleotide CDMO and CRDMO Services Product Offered
11.20.3 Asymchem Oligonucleotide CDMO and CRDMO Services Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Asymchem Main Business Overview
11.20.5 Asymchem Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oligonucleotide CDMO and CRDMO Services Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non-GMP Oligonucleotides
Table 4. Major Players of GMP Oligonucleotides
Table 5. Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Table 8. Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Table 11. Global Oligonucleotide CDMO and CRDMO Services Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Player (2020-2025)
Table 13. Oligonucleotide CDMO and CRDMO Services Key Players Head office and Products Offered
Table 14. Oligonucleotide CDMO and CRDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Table 19. Global Oligonucleotide CDMO and CRDMO Services Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Country (2020-2025)
Table 23. Americas Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Table 25. Americas Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Table 27. APAC Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Table 29. APAC Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Country (2020-2025)
Table 33. Europe Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oligonucleotide CDMO and CRDMO Services
Table 39. Key Market Challenges & Risks of Oligonucleotide CDMO and CRDMO Services
Table 40. Key Industry Trends of Oligonucleotide CDMO and CRDMO Services
Table 41. Global Oligonucleotide CDMO and CRDMO Services Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Oligonucleotide CDMO and CRDMO Services Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Oligonucleotide CDMO and CRDMO Services Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. ST Pharm Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 46. ST Pharm Oligonucleotide CDMO and CRDMO Services Product Offered
Table 47. ST Pharm Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. ST Pharm Main Business
Table 49. ST Pharm Latest Developments
Table 50. EUROAPI Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 51. EUROAPI Oligonucleotide CDMO and CRDMO Services Product Offered
Table 52. EUROAPI Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. EUROAPI Main Business
Table 54. EUROAPI Latest Developments
Table 55. Danaher(IDT) Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 56. Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Product Offered
Table 57. Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Danaher(IDT) Main Business
Table 59. Danaher(IDT) Latest Developments
Table 60. Merck Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 61. Merck Oligonucleotide CDMO and CRDMO Services Product Offered
Table 62. Merck Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Main Business
Table 64. Merck Latest Developments
Table 65. Eurofins Scientific Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 66. Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
Table 67. Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Eurofins Scientific Main Business
Table 69. Eurofins Scientific Latest Developments
Table 70. Thermo Fisher Scientific Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 71. Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
Table 72. Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Thermo Fisher Scientific Main Business
Table 74. Thermo Fisher Scientific Latest Developments
Table 75. Agilent Technologies Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 76. Agilent Technologies Oligonucleotide CDMO and CRDMO Services Product Offered
Table 77. Agilent Technologies Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies Latest Developments
Table 80. Nippon Shokubai Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 81. Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Product Offered
Table 82. Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Nippon Shokubai Main Business
Table 84. Nippon Shokubai Latest Developments
Table 85. Eurogentec Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 86. Eurogentec Oligonucleotide CDMO and CRDMO Services Product Offered
Table 87. Eurogentec Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Eurogentec Main Business
Table 89. Eurogentec Latest Developments
Table 90. Ajinomoto Bio-Pharma Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 91. Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
Table 92. Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Ajinomoto Bio-Pharma Main Business
Table 94. Ajinomoto Bio-Pharma Latest Developments
Table 95. PeptiStar Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 96. PeptiStar Oligonucleotide CDMO and CRDMO Services Product Offered
Table 97. PeptiStar Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. PeptiStar Main Business
Table 99. PeptiStar Latest Developments
Table 100. Bachem Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 101. Bachem Oligonucleotide CDMO and CRDMO Services Product Offered
Table 102. Bachem Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Bachem Main Business
Table 104. Bachem Latest Developments
Table 105. CordenPharma Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 106. CordenPharma Oligonucleotide CDMO and CRDMO Services Product Offered
Table 107. CordenPharma Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. CordenPharma Main Business
Table 109. CordenPharma Latest Developments
Table 110. Guangzhou RiboBio Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 111. Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Product Offered
Table 112. Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Guangzhou RiboBio Main Business
Table 114. Guangzhou RiboBio Latest Developments
Table 115. Hongene Biotech Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 116. Hongene Biotech Oligonucleotide CDMO and CRDMO Services Product Offered
Table 117. Hongene Biotech Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Hongene Biotech Main Business
Table 119. Hongene Biotech Latest Developments
Table 120. WuXi AppTec Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 121. WuXi AppTec Oligonucleotide CDMO and CRDMO Services Product Offered
Table 122. WuXi AppTec Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. WuXi AppTec Main Business
Table 124. WuXi AppTec Latest Developments
Table 125. Veliter Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 126. Veliter Oligonucleotide CDMO and CRDMO Services Product Offered
Table 127. Veliter Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Veliter Main Business
Table 129. Veliter Latest Developments
Table 130. Ribobay Pharma Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 131. Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
Table 132. Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Ribobay Pharma Main Business
Table 134. Ribobay Pharma Latest Developments
Table 135. ChemExpress Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 136. ChemExpress Oligonucleotide CDMO and CRDMO Services Product Offered
Table 137. ChemExpress Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. ChemExpress Main Business
Table 139. ChemExpress Latest Developments
Table 140. Asymchem Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 141. Asymchem Oligonucleotide CDMO and CRDMO Services Product Offered
Table 142. Asymchem Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Asymchem Main Business
Table 144. Asymchem Latest Developments
Table 1. Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Oligonucleotide CDMO and CRDMO Services Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Non-GMP Oligonucleotides
Table 4. Major Players of GMP Oligonucleotides
Table 5. Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Table 8. Oligonucleotide CDMO and CRDMO Services Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Table 11. Global Oligonucleotide CDMO and CRDMO Services Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Player (2020-2025)
Table 13. Oligonucleotide CDMO and CRDMO Services Key Players Head office and Products Offered
Table 14. Oligonucleotide CDMO and CRDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Table 19. Global Oligonucleotide CDMO and CRDMO Services Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Country (2020-2025)
Table 23. Americas Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Table 25. Americas Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Table 27. APAC Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Table 29. APAC Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Oligonucleotide CDMO and CRDMO Services Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Country (2020-2025)
Table 33. Europe Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Oligonucleotide CDMO and CRDMO Services
Table 39. Key Market Challenges & Risks of Oligonucleotide CDMO and CRDMO Services
Table 40. Key Industry Trends of Oligonucleotide CDMO and CRDMO Services
Table 41. Global Oligonucleotide CDMO and CRDMO Services Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Oligonucleotide CDMO and CRDMO Services Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Oligonucleotide CDMO and CRDMO Services Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. ST Pharm Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 46. ST Pharm Oligonucleotide CDMO and CRDMO Services Product Offered
Table 47. ST Pharm Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. ST Pharm Main Business
Table 49. ST Pharm Latest Developments
Table 50. EUROAPI Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 51. EUROAPI Oligonucleotide CDMO and CRDMO Services Product Offered
Table 52. EUROAPI Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. EUROAPI Main Business
Table 54. EUROAPI Latest Developments
Table 55. Danaher(IDT) Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 56. Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Product Offered
Table 57. Danaher(IDT) Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Danaher(IDT) Main Business
Table 59. Danaher(IDT) Latest Developments
Table 60. Merck Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 61. Merck Oligonucleotide CDMO and CRDMO Services Product Offered
Table 62. Merck Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Merck Main Business
Table 64. Merck Latest Developments
Table 65. Eurofins Scientific Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 66. Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
Table 67. Eurofins Scientific Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Eurofins Scientific Main Business
Table 69. Eurofins Scientific Latest Developments
Table 70. Thermo Fisher Scientific Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 71. Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Product Offered
Table 72. Thermo Fisher Scientific Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Thermo Fisher Scientific Main Business
Table 74. Thermo Fisher Scientific Latest Developments
Table 75. Agilent Technologies Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 76. Agilent Technologies Oligonucleotide CDMO and CRDMO Services Product Offered
Table 77. Agilent Technologies Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Agilent Technologies Main Business
Table 79. Agilent Technologies Latest Developments
Table 80. Nippon Shokubai Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 81. Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Product Offered
Table 82. Nippon Shokubai Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Nippon Shokubai Main Business
Table 84. Nippon Shokubai Latest Developments
Table 85. Eurogentec Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 86. Eurogentec Oligonucleotide CDMO and CRDMO Services Product Offered
Table 87. Eurogentec Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Eurogentec Main Business
Table 89. Eurogentec Latest Developments
Table 90. Ajinomoto Bio-Pharma Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 91. Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
Table 92. Ajinomoto Bio-Pharma Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Ajinomoto Bio-Pharma Main Business
Table 94. Ajinomoto Bio-Pharma Latest Developments
Table 95. PeptiStar Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 96. PeptiStar Oligonucleotide CDMO and CRDMO Services Product Offered
Table 97. PeptiStar Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. PeptiStar Main Business
Table 99. PeptiStar Latest Developments
Table 100. Bachem Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 101. Bachem Oligonucleotide CDMO and CRDMO Services Product Offered
Table 102. Bachem Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Bachem Main Business
Table 104. Bachem Latest Developments
Table 105. CordenPharma Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 106. CordenPharma Oligonucleotide CDMO and CRDMO Services Product Offered
Table 107. CordenPharma Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. CordenPharma Main Business
Table 109. CordenPharma Latest Developments
Table 110. Guangzhou RiboBio Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 111. Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Product Offered
Table 112. Guangzhou RiboBio Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Guangzhou RiboBio Main Business
Table 114. Guangzhou RiboBio Latest Developments
Table 115. Hongene Biotech Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 116. Hongene Biotech Oligonucleotide CDMO and CRDMO Services Product Offered
Table 117. Hongene Biotech Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. Hongene Biotech Main Business
Table 119. Hongene Biotech Latest Developments
Table 120. WuXi AppTec Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 121. WuXi AppTec Oligonucleotide CDMO and CRDMO Services Product Offered
Table 122. WuXi AppTec Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. WuXi AppTec Main Business
Table 124. WuXi AppTec Latest Developments
Table 125. Veliter Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 126. Veliter Oligonucleotide CDMO and CRDMO Services Product Offered
Table 127. Veliter Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 128. Veliter Main Business
Table 129. Veliter Latest Developments
Table 130. Ribobay Pharma Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 131. Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Product Offered
Table 132. Ribobay Pharma Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 133. Ribobay Pharma Main Business
Table 134. Ribobay Pharma Latest Developments
Table 135. ChemExpress Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 136. ChemExpress Oligonucleotide CDMO and CRDMO Services Product Offered
Table 137. ChemExpress Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 138. ChemExpress Main Business
Table 139. ChemExpress Latest Developments
Table 140. Asymchem Details, Company Type, Oligonucleotide CDMO and CRDMO Services Area Served and Its Competitors
Table 141. Asymchem Oligonucleotide CDMO and CRDMO Services Product Offered
Table 142. Asymchem Oligonucleotide CDMO and CRDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 143. Asymchem Main Business
Table 144. Asymchem Latest Developments
LIST OF FIGURES
Figure 1. Oligonucleotide CDMO and CRDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotide CDMO and CRDMO Services Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oligonucleotide CDMO and CRDMO Services Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oligonucleotide CDMO and CRDMO Services Sales Market Share by Country/Region (2024)
Figure 8. Oligonucleotide CDMO and CRDMO Services Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type in 2024
Figure 10. Oligonucleotide CDMO and CRDMO Services in Pharmaceuticals
Figure 11. Global Oligonucleotide CDMO and CRDMO Services Market: Pharmaceuticals (2020-2025) & ($ millions)
Figure 12. Oligonucleotide CDMO and CRDMO Services in Scientific Research
Figure 13. Global Oligonucleotide CDMO and CRDMO Services Market: Scientific Research (2020-2025) & ($ millions)
Figure 14. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application in 2024
Figure 15. Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Player in 2024
Figure 16. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Figure 17. Americas Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 18. APAC Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 19. Europe Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 21. Americas Oligonucleotide CDMO and CRDMO Services Value Market Share by Country in 2024
Figure 22. United States Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region in 2024
Figure 27. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Figure 28. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Figure 29. China Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 33. India Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Country in 2024
Figure 36. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Figure 37. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Figure 38. Germany Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 39. France Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 52. APAC Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 53. Europe Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 55. United States Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 56. Canada Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 57. Mexico Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 58. Brazil Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 59. China Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 60. Japan Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 61. Korea Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 63. India Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 64. Australia Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 65. Germany Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 66. France Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 67. UK Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 68. Italy Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 69. Russia Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 70. Egypt Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 71. South Africa Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 72. Israel Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 73. Turkey Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 74. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 1. Oligonucleotide CDMO and CRDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oligonucleotide CDMO and CRDMO Services Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Oligonucleotide CDMO and CRDMO Services Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Oligonucleotide CDMO and CRDMO Services Sales Market Share by Country/Region (2024)
Figure 8. Oligonucleotide CDMO and CRDMO Services Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type in 2024
Figure 10. Oligonucleotide CDMO and CRDMO Services in Pharmaceuticals
Figure 11. Global Oligonucleotide CDMO and CRDMO Services Market: Pharmaceuticals (2020-2025) & ($ millions)
Figure 12. Oligonucleotide CDMO and CRDMO Services in Scientific Research
Figure 13. Global Oligonucleotide CDMO and CRDMO Services Market: Scientific Research (2020-2025) & ($ millions)
Figure 14. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application in 2024
Figure 15. Global Oligonucleotide CDMO and CRDMO Services Revenue Market Share by Player in 2024
Figure 16. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Figure 17. Americas Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 18. APAC Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 19. Europe Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size 2020-2025 ($ millions)
Figure 21. Americas Oligonucleotide CDMO and CRDMO Services Value Market Share by Country in 2024
Figure 22. United States Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region in 2024
Figure 27. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Figure 28. APAC Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Figure 29. China Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 33. India Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Country in 2024
Figure 36. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Figure 37. Europe Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Figure 38. Germany Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 39. France Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Oligonucleotide CDMO and CRDMO Services Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 52. APAC Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 53. Europe Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 55. United States Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 56. Canada Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 57. Mexico Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 58. Brazil Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 59. China Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 60. Japan Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 61. Korea Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 63. India Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 64. Australia Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 65. Germany Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 66. France Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 67. UK Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 68. Italy Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 69. Russia Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 70. Egypt Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 71. South Africa Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 72. Israel Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 73. Turkey Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)
Figure 74. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Oligonucleotide CDMO and CRDMO Services Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Oligonucleotide CDMO and CRDMO Services Market Size 2026-2031 ($ millions)